Literature DB >> 6640897

Creatine kinase activity and isoenzyme pattern in various normal tissues and neoplasms.

S H Tsung.   

Abstract

I measured total creatine kinase (CK; EC 2.7.3.2) activity and isoenzyme pattern in normal and neoplastic tissues. CK activity was detected in all of them examined. In various tumors it was greater than, less than, or the same as that in normal tissue, no clear correlation being seen between total activity and growth rate or degree of differentiation. In several cases, there was a greater proportion of the CK-MM isoenzyme, and 15 of 53 cases showed an atypical CK-MM band. The atypical CK-MM band, also reported by others, might be an insensitive and nonspecific tumor marker. The CK-BB isoenzyme, ubiquitous in neoplastic tissues, might accordingly be a nonspecific marker. Total CK activity was very low in most tumor tissues. Presumably a bulky tumor or an advanced stage of malignancy is a requisite to release of routinely detectable CK-BB into the circulation.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6640897

Source DB:  PubMed          Journal:  Clin Chem        ISSN: 0009-9147            Impact factor:   8.327


  13 in total

1.  Inhibition of ubiquitous mitochondrial creatine kinase expression in HeLa cells by an antisense oligodeoxynucleotide.

Authors:  N Enjolras; C Godinot
Journal:  Mol Cell Biochem       Date:  1997-02       Impact factor: 3.396

2.  Creatine kinase isoenzymes: biochemical findings after therapeutical embolization of the hepatic artery in two patients with liver metastasis of an islet cell carcinoma or a carcinoid tumor.

Authors:  E SiragEldin; R Klapdor
Journal:  Klin Wochenschr       Date:  1985-03-15

3.  Ameliorative Potential of Rosuvastatin on Doxorubicin-induced Cardiotoxicity by Modulating Oxidative Damage in Rats

Authors:  Jayaraman Rajangam; Navaneetha Krishnan; Narahari N Palei; Shvetank Bhatt; Manas Kumar Das; Saumya Das; Krishnapillai Mathusoothanan
Journal:  Turk J Pharm Sci       Date:  2022-02-28

Review 4.  Creatine kinase in non-muscle tissues and cells.

Authors:  T Wallimann; W Hemmer
Journal:  Mol Cell Biochem       Date:  1994 Apr-May       Impact factor: 3.396

5.  Creatine CEST MRI for Differentiating Gliomas with Different Degrees of Aggressiveness.

Authors:  Kejia Cai; Rong-Wen Tain; Xiaohong Joe Zhou; Frederick C Damen; Alessandro M Scotti; Hari Hariharan; Harish Poptani; Ravinder Reddy
Journal:  Mol Imaging Biol       Date:  2017-04       Impact factor: 3.488

6.  CKMT1 regulates the mitochondrial permeability transition pore in a process that provides evidence for alternative forms of the complex.

Authors:  Christoph Datler; Evangelos Pazarentzos; Anne-Laure Mahul-Mellier; Wanwisa Chaisaklert; Ming-Shih Hwang; Foy Osborne; Stefan Grimm
Journal:  J Cell Sci       Date:  2014-02-12       Impact factor: 5.285

7.  Creatine kinase activity and isoenzymes in lung, colon and liver carcinomas.

Authors:  J Joseph; A Cardesa; J Carreras
Journal:  Br J Cancer       Date:  1997       Impact factor: 7.640

8.  Low serum creatine kinase levels in breast cancer patients: a case-control study.

Authors:  Hong Pan; Kai Xia; Wenbin Zhou; Jinqiu Xue; Xiuqing Liang; Lin Cheng; Naping Wu; Mengdi Liang; Dan Wu; Lijun Ling; Qiang Ding; Lin Chen; Xiaoming Zha; Xiaoan Liu; Shui Wang
Journal:  PLoS One       Date:  2013-04-15       Impact factor: 3.240

9.  Phosphoglycerate mutase, 2,3-bisphosphoglycerate phosphatase and creatine kinase activity and isoenzymes in human brain tumours.

Authors:  N Durany; J Joseph; F F Cruz-Sánchez; J Carreras
Journal:  Br J Cancer       Date:  1997       Impact factor: 7.640

10.  Creatine kinase BB isoenzyme levels in tumour cytosols and survival of breast cancer patients.

Authors:  N Zarghami; M Giai; H Yu; R Roagna; R Ponzone; D Katsaros; P Sismondi; E P Diamandis
Journal:  Br J Cancer       Date:  1996-02       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.